GH1 and metabolic dysfunction-associated steatohepatitis: In summary, our studies suggest that reduced hepatic GH action in obese subjects with NASH has detrimental effects on glucose tolerance by diminishing hepatic insulin signaling and increasing hepatic glucose output.